Loading...
ChromaDex Corporation
CDXC•NASDAQ
Healthcare
Biotechnology
$7.87
$-0.07(-0.88%)
ChromaDex Corporation (CDXC) Financial Performance & Statements
Review ChromaDex Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
19.18%
↑ 19.18%
Operating Income Growth
237.99%
↑ 237.99%
Net Income Growth
273.15%
↑ 273.15%
Operating Cash Flow Growth
70.14%
↑ 70.14%
Operating Margin
16.28%
↑ 16.28%
Gross Margin
77.73%
↑ 77.73%
Net Profit Margin
16.25%
↑ 16.25%
ROE
33.88%
↑ 33.88%
ROIC
23.35%
↑ 23.35%
ChromaDex Corporation (CDXC) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for ChromaDex Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $29.13M | $25.58M | $22.74M | $22.15M |
| Cost of Revenue | $10.93M | $9.34M | $9.05M | $8.70M |
| Gross Profit | $18.20M | $16.24M | $13.69M | $13.46M |
| Gross Profit Ratio | $0.62 | $0.63 | $0.60 | $0.61 |
| R&D Expenses | $1.31M | $1.29M | $1.32M | $2.10M |
| SG&A Expenses | $9.77M | $13.35M | $12.63M | $12.09M |
| Operating Expenses | $11.09M | $14.64M | $13.95M | $14.19M |
| Total Costs & Expenses | $22.01M | $23.98M | $23.00M | $22.88M |
| Interest Income | $373000.00 | $276000.00 | $241000.00 | $239000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $358000.00 | $366000.00 | $370000.00 | $390000.00 |
| EBITDA | $7.47M | $1.97M | $114000.00 | -$341000.00 |
| EBITDA Ratio | $0.26 | $0.08 | $0.005 | -$0.02 |
| Operating Income | $7.11M | $1.60M | -$256000.00 | -$731000.00 |
| Operating Income Ratio | $0.24 | $0.06 | -$0.01 | -$0.03 |
| Other Income/Expenses (Net) | $373000.00 | $276000.00 | $241000.00 | $239000.00 |
| Income Before Tax | $7.48M | $1.88M | -$15000.00 | -$492000.00 |
| Income Before Tax Ratio | $0.26 | $0.07 | -$0.001 | -$0.02 |
| Income Tax Expense | $305000.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $7.18M | $1.88M | -$15000.00 | -$492000.00 |
| Net Income Ratio | $0.25 | $0.07 | -$0.001 | -$0.02 |
| EPS | $0.09 | $0.02 | -$0.00 | -$0.006 |
| Diluted EPS | $0.09 | $0.02 | -$0.00 | -$0.006 |
| Weighted Avg Shares Outstanding | $76.94M | $93.90M | $75.56M | $75.23M |
| Weighted Avg Shares Outstanding (Diluted) | $81.68M | $77.77M | $75.56M | $75.23M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan